Drupal.behaviors.print = function(context) {window.print();window.close();}>
Rosetta Genomics to Sell $1.9M in Securities, Inks miRNA Dx Distribution Deal for China
October 13, 2011
Rosetta Genomics to Sell $1.9M in Securities, Inks miRNA Dx Distribution Deal for China
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
After Raising Cash, Rosetta Aims to Restart R&D Efforts, Get Additional Medicare Approvals
October 4, 2012 / Gene Silencing News
Rosetta Genomics Terminates Deal with Avatao
July 17, 2012 / GenomeWeb Daily News
Rosetta Publishes Data on Cancer of Unknown Primary Origin Test
May 31, 2012 / Gene Silencing News
After Medicare Nod for CUP Diagnostic, Rosetta Aims to Get Coverage for Other miRNA Tests
May 24, 2012 / Gene Silencing News
Rosetta Stock Rises on Reverse Stock Split, Kidney Test Launch, Medicare Coverage of CUP Dx
May 17, 2012 / Gene Silencing News